Works by Rubio, Maria Jesus


Results: 14
    1
    3

    SEOM–GEICO clinical guideline on epithelial ovarian cancer (2023).

    Published in:
    Clinical & Translational Oncology, 2024, v. 26, n. 11, p. 2758, doi. 10.1007/s12094-024-03531-3
    By:
    • Perez-Fidalgo, Jose Alejandro;
    • Gálvez-Montosa, Fernando;
    • Guerra, Eva María;
    • Madariaga, Ainhoa;
    • Manzano, Aranzazu;
    • Martin-Lorente, Cristina;
    • Rubio-Pérez, Maria Jesús;
    • Alarcón, Jesus;
    • Barretina-Ginesta, María Pilar;
    • Gaba, Lydia
    Publication type:
    Article
    4

    Effect of Tofacitinib on Hemostasis in Patients with Ulcerative Colitis: A Comparative Ex Vivo Study.

    Published in:
    Pharmaceuticals (14248247), 2025, v. 18, n. 4, p. 557, doi. 10.3390/ph18040557
    By:
    • Sánchez-Sánchez, Cristina;
    • Suarez-Trujillo, Fabio;
    • Ramírez, Cristina;
    • Soleto, Irene;
    • Mercado, Jorge;
    • Orejudo, Macarena;
    • Martínez, Paula J.;
    • Rubio Collado, Celia;
    • Orts, Mar;
    • Rubio Franco, María Jesús;
    • Planas, Antonio;
    • Acedo, Natalia;
    • Butta, Nora;
    • Chaparro, María;
    • Gisbert, Javier P.;
    • Baldán-Martín, Montse
    Publication type:
    Article
    5
    6

    Management of advanced ovarian cancer in Spain: an expert Delphi consensus.

    Published in:
    Journal of Ovarian Research, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13048-021-00816-x
    By:
    • Redondo, Andres;
    • Oaknin, Ana;
    • Rubio, Maria Jesus;
    • Barretina-Ginesta, Maria-Pilar;
    • de Juan, Ana;
    • Manso, Luis;
    • Romero, Ignacio;
    • Martin-Lorente, Cristina;
    • Poveda, Andres;
    • Gonzalez-Martin, Antonio
    Publication type:
    Article
    7
    8
    9

    Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network.

    Published in:
    Cancers, 2022, v. 14, n. 8, p. 1965, doi. 10.3390/cancers14081965
    By:
    • López-Guerrero, José Antonio;
    • Mendiola, Marta;
    • Pérez-Fidalgo, José Alejandro;
    • Romero, Ignacio;
    • Torres, Ana;
    • Recalde, Delia;
    • Molina, Elena;
    • Gómez-Raposo, César;
    • Levin, Ana M.;
    • Herrero, Ana;
    • Alarcón, Jesús;
    • Esteban, Carmen;
    • Marquina, Gloria;
    • Rubio, María Jesús;
    • Guerra, Eva;
    • Sánchez-Lorenzo, Luisa;
    • Gálvez-Montosa, Fernando;
    • de Juan, Ana;
    • Churruca, Cristina;
    • Gallego, Alejandro
    Publication type:
    Article
    10

    Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study.

    Published in:
    Cancers, 2022, v. 14, n. 4, p. 915, doi. 10.3390/cancers14040915
    By:
    • Poveda, Andres;
    • Lopez-Reig, Raquel;
    • Oaknin, Ana;
    • Redondo, Andres;
    • Rubio, Maria Jesus;
    • Guerra, Eva;
    • Fariñas-Madrid, Lorena;
    • Gallego, Alejandro;
    • Rodriguez-Freixinos, Victor;
    • Fernandez-Serra, Antonio;
    • Juan, Oscar;
    • Romero, Ignacio;
    • Lopez-Guerrero, Jose A.
    Publication type:
    Article
    11

    Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.

    Published in:
    Clinical & Translational Oncology, 2023, v. 25, n. 7, p. 2090, doi. 10.1007/s12094-023-03085-w
    By:
    • Garcia-Donas, Jesus;
    • Hurtado, Alicia;
    • Garrigos, Laia;
    • Santaballa, Ana;
    • Redondo, Andres;
    • Vidal, Laura;
    • Lainez, Nuria;
    • Guerra, Eva;
    • Rodriguez, Victor;
    • Cueva, Juan;
    • Bover, Isabel;
    • Palacio, Isabel;
    • Rubio, Maria Jesus;
    • Prieto, Mario;
    • Lopez-Guerrero, Jose Antonio;
    • Rodriguez-Moreno, Juan Francisco;
    • Garcia-Casado, Zaida;
    • Garcia-Martinez, Elena;
    • Taus, Alvaro;
    • de Castro, Ignacio Pérez
    Publication type:
    Article
    12

    SEOM-GEICO clinical guidelines on endometrial cancer (2021).

    Published in:
    Clinical & Translational Oncology, 2022, v. 24, n. 4, p. 625, doi. 10.1007/s12094-022-02799-7
    By:
    • Barretina-Ginesta, María Pilar;
    • Quindós, María;
    • Alarcón, Jesús Damián;
    • Esteban, Carmen;
    • Gaba, Lydia;
    • Gómez, César;
    • Fidalgo, José Alejandro Pérez;
    • Romero, Ignacio;
    • Santaballa, Ana;
    • Rubio-Pérez, María Jesús
    Publication type:
    Article
    13

    DOMENICA study (GINECO-EN105b/ENGO-Ten13): randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting (APGOT-EN1).

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, p. 19, doi. 10.3802/jgo.2024.35.S2.P1
    By:
    • Chel Hun Choi;
    • Ray-Coquard, Isabelle;
    • Rubio, Maria Jesus;
    • Paoletti, Xavier;
    • Hudson, Emma;
    • Lorusso, Domenica;
    • Hasler-Strub, Ursula;
    • Vardar, Mehmet Ali;
    • Lheureux, Stéphanie;
    • Van Gorp, Toon;
    • Shao Peng Tan, David;
    • Trillsch, Fabian;
    • Eberst, Lauriane;
    • Lescure, Céline;
    • Hardy-Bessard, Anne-Claire;
    • Chaix, Marie;
    • Byoung-Gie Kim;
    • JaeWeon Kim;
    • JeongYeol Park;
    • Jung-Yun Lee
    Publication type:
    Article
    14